alazocine developmental code name also known commonly nallylnormetazocine nanm synthetic opioid analgesic benzomorphan family related metazocine never addition opioid activity drug sigma receptor agonist used widely scientific research studies alazocine described potent analgesic psychotomimetic hallucinogen opioid moreover one enantiomers first compound found selectively label receptor led discovery characterization alazocine shows stereoselectivity nonselective highaffinity ligand μ κ δopioid receptors ki nm guinea pig brain membranes low affinity sigma receptor ki nm guinea pig brain acts moderateefficacy partial agonist κopioid receptor ki nm nm emax mouse receptor transfected antagonist μopioid receptor ki nm mouse receptor transfected also agonist δopioid receptor far lower potency ki reported nm imax mouse receptor transfected conversely stereoisomer little affinity opioid receptors ki nm nm nm μ κ δopioid receptors guinea pig brain membranes instead selective highaffinity agonist receptor ki nm guinea pig brain however enantiomer also shows moderate affinity dizocilpine phencyclidine pcp site nmda receptor ki nm rat brain membranes relative nm receptor hence uncompetitive nmda receptor antagonist well higher alazocine modestly selective ligand enantiomers alazocine low affinity sigma receptor ki nm nm respectively rat brain membranes rat due high affinity receptor alazocine used distinguish two sigma receptor subtypes scientific research instance radioligand binding taken together selective partial agonist κopioid receptor antagonist μopioid receptor far lesser extent agonist δopioid low affinity sigma receptors alazocine selective agonist sigma receptor lesser extent antagonist nmda receptor low affinity opioid sigma alazocine one early members benzomorphan family opioid analgesics first described scientific literature development resulted nalorphine nallylnormorphine potent analgesic opioid antagonist similar pharmacology introduced alazocine found produce strong psychotomimetic effects humans developed clinical subsequently benzomorphans pentazocine ndimethylallylbenzomorphan cyclazocine ncyclopropylmethylbenzomorphan phenazocine nphenylethylbenzomorphan developed marketed use sigma receptor named alazocine described prototypical receptor initially thought opioid receptor confused nmda receptor time ultimately distinguished psychotomimetic effects alazocine benzomorphans initially attributed incorrectly agonism receptor subsequent research established effects fact caused agonism κopioid receptor andor antagonism nmda sigma receptor discovered named identified part due dramatically reduced affinity alazocine receptor relative receptor contrast nonselective ligands like haloperidol ditolylguanidine show similar affinity httpsenwikipediaorgwikialazocine